INHALANT FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND CORTICOSTEROID
摘要
An inhalable unit dose liquid formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can be included in a kit. The formulation is administered as an aqueóus solution or concentrated composition. The formulation is employed in an improved nebulization system for administering corticosteroid by inhalation. SAE-CD present in the formulation significantly enhances the chemical stability of corticosteroid, such as budesonide. A method of administering the formulation by inhalation is provided. The formulation can also be administered by conventional nasal delivery apparatus. The formulation is prepared by mixing SAE-CD, in solid or liquid (dissolved) form, with an inhalable suspension-based unit dose formulation.
申请公布号
EP1732512(B1)
申请公布日期
2017.03.22
申请号
EP20050704917
申请日期
2004.12.31
申请人
CyDex Pharmaceuticals, Inc.
发明人
PIPKIN, James, D.;ZIMMERER, Rupert, O.;THOMPSON, Diane, O.;MOSHER, Gerold, L.